Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design

Walter P. Maksymowych, Oliver FitzGerald, George A. Wells, Dafna D. Gladman, Robert Landewé, Mikkel Østergaard, William J. Taylor, Robin Christensen, Paul Peter Tak, Maarten Boers, Silje W. Syversen, Joan M. Bathon, Christopher J. Ritchlin, Philip J. Mease, Vivien P. Bykerk, Patrick Garnero, Piet Geusens, Hani El-Gabalawy, Daniel Aletaha, Robert D. InmanVirginia Byers Kraus, Tore K. Kvien, Désirée Van Der Heijde

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design'. Together they form a unique fingerprint.

Medicine & Life Sciences